SCHEMBL23747294

SCHEMBL23747294

Cc1cccnc1C(C)NC(=O)C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.43
KDM4E B2RXH2 5/20 0.42
HTT P42858 4/20 0.42
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
NPC1 O15118 5/20 0.41
L3MBTL1 Q9Y468 4/20 0.41
LMNA P02545 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
MITF O75030 1/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
ALOX12 P18054 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
FDPS P14324 2/20 0.39
NSD2 O96028 1/20 0.39
SETD2 Q9BYW2 1/20 0.39
RAB9A P51151 4/20 0.39
ATM Q13315 1/20 0.38
KMT2A Q03164 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23747295 0.85 L3MBTL1 (0.47) MAPK1KDM4EHTTSMN1; SMN2NPC1
SCHEMBL20851535 0.75 NOS3 (0.42) MAPK1KDM4ESMN1; SMN2NPC1L3MBTL1
SCHEMBL5456877 0.74 NPC1 (0.42) MAPK1KDM4EHTTSMN1; SMN2NPC1
SCHEMBL19728695 0.73 SMN1; SMN2 (0.65) MAPK1KDM4EHTTALDH1A1SMN1; SMN2
SCHEMBL19699507 0.73 ALDH1A1 (0.51) MAPK1KDM4EHTTALDH1A1NPC1
SCHEMBL19699482 0.73 ALDH1A1 (0.51) MAPK1KDM4EHTTALDH1A1NPC1
SCHEMBL10311686 0.73 ALDH1A1 (0.51) MAPK1KDM4EHTTALDH1A1NPC1
SCHEMBL19324095 0.73 L3MBTL1 (0.45) MAPK1KDM4EHTTALDH1A1SMN1; SMN2
SCHEMBL3741239 0.73 SMN1; SMN2 (0.42) MAPK1KDM4EHTTSMN1; SMN2NPC1
SCHEMBL827728 0.72 NOS3 (0.50) KDM4EHTTNPC1L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
WO-2021159015-A1 NAMPT MODULATORS CYTOKINETICS, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 MAPK1 846/4885KDM4E 2721/4885HTT 1174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.